FOI 6278 - Biologic and biosimilar prescribing in rheumatology

Date: 29 September 2020 to 29 September 2023

Q1. How many patients have been treated with biologics or biosimilar products in the last 12 months for the following conditions:

  • Rheumatoid Arthritis  
  • Psoriatic Arthritis 
  • Ankylosing Spondylitis
  • Non-Radiographic Axial Spondyloarthritis 

 

Q2. Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 12 months with the following drugs. 

  • Request ID:
    6278
  • Category:
    Clinical - Drugs
  • Response:

    September 2020

    Q1. How many patients have been treated with biologics or biosimilar products in the last 12 months for the following conditions.  Medway NHS Foundation regret that we are unable to answer your query as this data is not collated.  However, we are able to confirm the number of patients that have been treated for the following diagnosis but we are unable to confirm whether or not they were treated with biologics or biosimilar products:

    • Rheumatoid Arthritis  895 
    • Psoriatic Arthritis  38
    • Ankylosing Spondylitis 42
    • Non-Radiographic Axial Spondyloarthritis  We regret we are unable to provide this data as this diagnosis does not have a dedicated clinical code.

     

    Q2. Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 12 months with the following drugs.  Please see table below showing data from 01/07/2019 to 31/08/2020.

     

    Drug Name, Strength and Form

    Number of Patients on Drug

    ABATACEPT 250 mg Injection

    8

    HOMECARE ABATACEPT (ORENICA) 125 mg Pre-filled Syringe

    41

    HOMECARE ABATACEPT CLICKJECT (ORENICA) 125 mg in 1ml Subcutaneous Injection

    53

    HOMECARE ADALIMUMAB (AMGEVITA) 40 mg in 0.8ml Pre-filled Pen

    6

    HOMECARE ADALIMUMAB (HUMIRA) 40 mg in 0.4ml Pre-filled Pen

    133

    HOMECARE ADALIMUMAB (IMRALDI) 40 mg in 0.8ml Pre-filled Pen

    297

    HOMECARE BARICITINIB (OLUMIANT) 2 mg Tablets

    7

    HOMECARE BARICITINIB (OLUMIANT) 4 mg Tablets

    21

    HOMECARE CERTOLIZUMAB PEGOL (CIMZIA) 200 mg in 1ml Pre-filled Syringe

    29

    HOMECARE ETANERCEPT (BENEPALI) 25 mg Pre-filled Syringe

    8

    HOMECARE ETANERCEPT (BENEPALI) 50 mg Pre-filled Pen

    334

    HOMECARE ETANERCEPT (BENEPALI) 50 mg Pre-filled Syringe

    44

    HOMECARE ETANERCEPT (ENBREL) 25 mg Pre-filled Syringe

    7

    HOMECARE ETANERCEPT (ENBREL) 50 mg Pre-filled Pen

    34

    HOMECARE ETANERCEPT (ENBREL) 50 mg Pre-filled Syringe

    9

    HOMECARE GOLIMUMAB (SIMPONI) 100 mg Pre-filled Pen

    20

    HOMECARE GOLIMUMAB (SIMPONI) 50 mg Pre-filled Pen

    147

    HOMECARE GOLIMUMAB (SIMPONI) 50 mg Pre-filled Syringe

    <5

    HOMECARE INFLIXIMAB (REMSIMA) 120 mg Pre-filled Pen

    20

    HOMECARE SECUKINUMAB (COSENTYX) 150 mg Pre-filled Pen

    36

    HOMECARE TOCILIZUMAB (ROACTEMRA) 162 mg in 0.9ml  Pre-filled Pen

    55

    HOMECARE TOCILIZUMAB (ROACTEMRA) 162 mg in 0.9ml Pre-filled Syringe

    80

    HOMECARE TOCILIZUMAB NURSE VISIT CHARGE

    20

    HOMECARE TOFACITINIB (XELJANZ) 5 mg Tablets

    5

    HOMECARE USTEKINUMAB (STELARA) 45 mg Pre-filled Syringe

    8

    inFLIXimab (INFLECTRA) 100 mg Intravenous Infusion

    12

    inFLIXimab (REMICADE) 100 mg Intravenous Infusion

    17

    inFLIXimab (REMSIMA) 100 mg Intravenous Infusion

    22

    riTUXimab (TRUXIMA) 100 mg Injection

    <5

    riTUXimab (TRUXIMA) 500 mg Injection

    45

    TOCILIZUMAB 200 mg in 10ml Solution for Infusion

    30

    TOCILIZUMAB 400 mg in 20ml Solution for Infusion

    50

    TOFACITINIB (XELJANZ) 5 mg Tablets

    <5